Edition:
United Kingdom

Kyowa Hakko Kirin Co Ltd (4151.T)

4151.T on Tokyo Stock Exchange

2,328JPY
18 Jun 2018
Change (% chg)

¥-29 (-1.23%)
Prev Close
¥2,357
Open
¥2,355
Day's High
¥2,357
Day's Low
¥2,326
Volume
572,700
Avg. Vol
1,267,069
52-wk High
¥2,478
52-wk Low
¥1,785

Chart for

About

Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of... (more)

Overall

Beta: 0.76
Market Cap(Mil.): ¥1,129,908.00
Shares Outstanding(Mil.): 576.48
Dividend: 12.50
Yield (%): 1.28

Financials

  4151.T Industry Sector
P/E (TTM): 49.76 30.95 32.75
EPS (TTM): 39.39 -- --
ROI: 3.49 14.84 14.38
ROE: 3.58 16.34 16.07

BRIEF-Aevi Genomic Medicine Expands Collaboration With Kyowa Hakko Kirin Co

* AEVI GENOMIC MEDICINE INC - EXPANDED COLLABORATION WITH KYOWA HAKKO KIRIN CO LTD

07 Mar 2018

BRIEF-Kyowa Kirin, Ultragenyx Announce Crysvita Receives Conditional Marketing Authorization In Europe For The Treatment Of X–Linked Hypophosphatemia In Children

* KYOWA KIRIN AND ULTRAGENYX ANNOUNCE CRYSVITA® (BUROSUMAB) RECEIVES CONDITIONAL MARKETING AUTHORIZATION IN EUROPE FOR THE TREATMENT OF X–LINKED HYPOPHOSPHATEMIA IN CHILDREN

23 Feb 2018

BRIEF-Kyowa Hakko Kirin appoints KPMG AZSA LLC as new corporate auditor

* Says it appoints KPMG AZSA LLC as new corporate auditor, to replace Ernst & Young ShinNihon LLC, effective March 23

21 Feb 2018

BRIEF- Kyowa Hakko Kirin sells 66.6 pct stake in unit Kyowa Medex

* Says it sold 66.6 percent stake in wholly owned unit Kyowa Medex Co., Ltd., to Hitachi Chemical Company, Ltd, on Jan. 4

04 Jan 2018

Earnings vs. Estimates